Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31Provision of specialist medical treatment2024-04-01false64truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 13706692 2024-04-01 2025-03-31 13706692 2023-04-01 2024-03-31 13706692 2025-03-31 13706692 2024-03-31 13706692 c:Director2 2024-04-01 2025-03-31 13706692 d:MotorVehicles 2024-04-01 2025-03-31 13706692 d:MotorVehicles 2025-03-31 13706692 d:MotorVehicles 2024-03-31 13706692 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 13706692 d:OfficeEquipment 2024-04-01 2025-03-31 13706692 d:OfficeEquipment 2025-03-31 13706692 d:OfficeEquipment 2024-03-31 13706692 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 13706692 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 13706692 d:ComputerEquipment 2024-04-01 2025-03-31 13706692 d:ComputerEquipment 2025-03-31 13706692 d:ComputerEquipment 2024-03-31 13706692 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 13706692 d:ComputerEquipment d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 13706692 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 13706692 d:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 13706692 d:Goodwill 2025-03-31 13706692 d:Goodwill 2024-03-31 13706692 d:CurrentFinancialInstruments 2025-03-31 13706692 d:CurrentFinancialInstruments 2024-03-31 13706692 d:Non-currentFinancialInstruments 2025-03-31 13706692 d:Non-currentFinancialInstruments 2024-03-31 13706692 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 13706692 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 13706692 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 13706692 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 13706692 d:ShareCapital 2025-03-31 13706692 d:ShareCapital 2024-03-31 13706692 d:RetainedEarningsAccumulatedLosses 2025-03-31 13706692 d:RetainedEarningsAccumulatedLosses 2024-03-31 13706692 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 13706692 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 13706692 c:OrdinaryShareClass1 2024-04-01 2025-03-31 13706692 c:OrdinaryShareClass1 2025-03-31 13706692 c:OrdinaryShareClass1 2024-03-31 13706692 c:OrdinaryShareClass2 2024-04-01 2025-03-31 13706692 c:OrdinaryShareClass2 2025-03-31 13706692 c:OrdinaryShareClass2 2024-03-31 13706692 c:OrdinaryShareClass3 2024-04-01 2025-03-31 13706692 c:OrdinaryShareClass3 2025-03-31 13706692 c:OrdinaryShareClass3 2024-03-31 13706692 c:FRS102 2024-04-01 2025-03-31 13706692 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13706692 c:FullAccounts 2024-04-01 2025-03-31 13706692 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13706692 6 2024-04-01 2025-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2025-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-03-31 13706692 d:Goodwill d:OwnedIntangibleAssets 2024-04-01 2025-03-31 13706692 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13706692









WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
REGISTERED NUMBER: 13706692

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2025
2024
2024
Note
£
£
£
£

FIXED ASSETS
  

Intangible assets
 4 
197,500
227,500

Tangible assets
 5 
93,786
27,776

Investments
 6 
240,344
139,630

  
531,630
394,906

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 7 
147,968
185,341

Cash at bank and in hand
  
344,385
248,706

  
492,353
434,047

Creditors: amounts falling due within one year
 8 
(241,516)
(362,558)

NET CURRENT ASSETS
  
 
 
250,837
 
 
71,489

TOTAL ASSETS LESS CURRENT LIABILITIES
  
782,467
466,395

Creditors: amounts falling due after more than one year
 9 
(60,729)
(8,064)

PROVISIONS FOR LIABILITIES
  

Deferred tax
 10 
(22,824)
(6,185)

  
 
 
(22,824)
 
 
(6,185)

NET ASSETS
  
698,914
452,146


CAPITAL AND RESERVES
  

Called up share capital 
 11 
100
100

Profit and loss account
  
698,814
452,046

  
698,914
452,146


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

Page 1

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
REGISTERED NUMBER: 13706692
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr G C Martinez-Munoz
Director

Date: 25 November 2025

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


GENERAL INFORMATION

West Cambridge Anaesthetists Group Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is Conqueror House, Chivers Way, Histon, Cambridge, CB24 9ZR.
The Company's functional and presentational currency is GBP.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

TURNOVER

Turnover comprises revenue recognised by the Company in respect of anaesthesia services supplied during the year, exclusive of Value Added Tax. Revenue is recognised as the fair value of the consideration received or receivable and is recognised based on the date the service is provided.

 
2.3

LEASED ASSETS: THE COMPANY AS LESSEE

Assets obtained under hire purchase contracts are capitalised as tangible fixed assets and depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Page 3

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

CURRENT AND DEFERRED TAXATION

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.5

INTANGIBLE ASSETS

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of Income and Retained Earnings over its useful economic life.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.6

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)


2.6
TANGIBLE FIXED ASSETS (CONTINUED)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line or reducing balance method.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
reducing balance
Office equipment and furniture
-
25%
straight line
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

VALUATION OF INVESTMENTS

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.8

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.11

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.12

DIVIDENDS

Equity dividends are recognised when they become legally payable. 


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 6 (2024 - 4).


4.


INTANGIBLE ASSETS




Goodwill

£



COST


At 1 April 2024
300,000



At 31 March 2025

300,000



AMORTISATION


At 1 April 2024
72,500


Charge for the year on owned assets
30,000



At 31 March 2025

102,500



NET BOOK VALUE



At 31 March 2025
197,500



At 31 March 2024
227,500



Page 6

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


TANGIBLE FIXED ASSETS





Motor vehicles
Office equipment and furniture
Computer equipment
Total

£
£
£
£



COST


At 1 April 2024
39,624
1,478
9,648
50,750


Additions
76,200
6,988
2,838
86,026


Disposals
-
(502)
(4,627)
(5,129)



At 31 March 2025

115,824
7,964
7,859
131,647



DEPRECIATION


At 1 April 2024
16,097
838
6,039
22,974


Charge for the year on owned assets
-
1,063
1,929
2,992


Charge for the year on financed assets
15,407
-
-
15,407


Disposals
-
(303)
(3,209)
(3,512)



At 31 March 2025

31,504
1,598
4,759
37,861



NET BOOK VALUE



At 31 March 2025
84,320
6,366
3,100
93,786



At 31 March 2024
23,527
640
3,609
27,776

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2025
2024
£
£



Motor vehicles
84,320
23,527

Page 7

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


FIXED ASSET INVESTMENTS





Listed investments
Unlisted investments
Total

£
£
£



COST OR VALUATION


At 1 April 2024
89,633
49,997
139,630


Additions
61,376
9,500
70,876


Revaluations
29,838
-
29,838



At 31 March 2025
180,847
59,497
240,344





7.


DEBTORS

2025
2024
£
£


Trade debtors
147,968
180,341

Other debtors
-
5,000

147,968
185,341



8.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025
2024
£
£

Corporation tax
71,615
36,785

Other taxation and social security
529
1,479

Obligations under finance lease and hire purchase contracts
16,683
7,223

Other creditors
147,251
84,578

Accruals and deferred income
5,438
232,493

241,516
362,558


Obligations under finance lease and hire purchase contracts are secured against the assets concerned.
Other creditors include contributions of £176 (2024 - £330) payable to the Company's defined contribution pension scheme at the balance sheet date.

Page 8

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025
2024
£
£

Net obligations under finance leases and hire purchase contracts
60,729
8,064


Obligations under finance lease and hire purchase contracts are secured against the assets concerned.


10.


DEFERRED TAXATION




2025


£






At beginning of year
6,185


Charged to profit or loss
16,639



AT END OF YEAR
22,824

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
22,824
6,185


11.


SHARE CAPITAL

2025
2024
£
£
ALLOTTED, CALLED UP AND FULLY PAID



50 (2024 - 50) Ordinary A shares of £1 each
50
50
40 (2024 - 40) Ordinary B shares of £1 each
40
40
10 (2024 - 10) Ordinary C shares of £1 each
10
10

100

100


 
Page 9